Read More 1 minute read Analyst Ratings News Price Target Reiteration Canaccord Genuity Reiterates Buy on Nuvei, Maintains $70 Price Target By Benzinga Newsdesk Today, 6:19 AM Canaccord Genuity analyst Joseph Vafi reiterates Nuvei (NASDAQ:NVEI) with a Buy and maintains $70 price target. NVEI
Read More 1 minute read Analyst Ratings News Price Target Reiteration DA Davidson Reiterates Buy on Mattel, Maintains $23 Price Target By Benzinga Newsdesk Today, 6:19 AM DA Davidson analyst Linda Bolton Weiser reiterates Mattel (NASDAQ:MAT) with a Buy and maintains $23 price target. MAT
Read More 1 minute read Analyst Color Analyst Ratings General News Price Target Reiteration Trip.com Analyst Bumps Up Price Target By 9% As Recovery Underway By Shivani Kumaresan Today, 6:19 AM Mizuho analyst James Lee reiterated a Buy rating on the shares of Trip.com Group Ltd (NASDAQ:TCOM) and raised the price target from… TCOM
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Overweight on Indaptus Therapeutics, Maintains $15 Price Target By Benzinga Newsdesk Today, 6:19 AM HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Indaptus Therapeutics (NASDAQ:INDP) with a Overweight and maintains $15 price target. INDP
Read More 2 minute read Analyst Color Analyst Ratings Price Target Reiteration Tech Apple Stock Gets Price Target Bump On Rebounding Chinese iPhone Demand And This ‘Unappreciated Asset’ By Shanthi Rexaline Today, 6:19 AM Sell-side’s optimism concerning Apple, Inc. (NASDAQ: AAPL) has been on the rise. AAPL
Read More 1 minute read Analyst Ratings News Price Target Reiteration Cantor Fitzgerald Reiterates Overweight on Marinus Pharma, Maintains $28 Price Target By Benzinga Newsdesk Today, 6:19 AM Cantor Fitzgerald analyst Charles Duncan reiterates Marinus Pharma (NASDAQ:MRNS) with a Overweight and maintains $28 price target. MRNS
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Neuronetics, Maintains $12 Price Target By Benzinga Newsdesk Today, 6:19 AM JMP Securities analyst David Turkaly reiterates Neuronetics (NASDAQ:STIM) with a Market Outperform and maintains $12 price target. STIM
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Sector Perform on B2Gold, Maintains $4.25 Price Target By Benzinga Newsdesk Today, 6:19 AM RBC Capital analyst Josh Wolfson reiterates B2Gold (AMEX:BTG) with a Sector Perform and maintains $4.25 price target. BTG
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on JFrog, Maintains $28 Price Target By Benzinga Newsdesk Today, 6:19 AM Needham analyst Mike Cikos reiterates JFrog (NASDAQ:FROG) with a Buy and maintains $28 price target. FROG
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Pros Holdings, Maintains $35 Price Target By Benzinga Newsdesk Today, 6:19 AM Needham analyst Scott Berg reiterates Pros Holdings (NYSE:PRO) with a Buy and maintains $35 price target. PRO